In8Bio INAB Cash Flow Statement (2020-2026)

NASDAQ INAB
$1.04 +0.05 (+4.55%)
As of: Oct 23, 2026 · 3:59 PM EDT
Reported Financials

In8Bio Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

In8Bio reported cash from operations of -$3.75M and free cash flow of -$3.98M for the quarter ended Jun 2026, up 4.6% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-3.39M-5.85M-6.15M-7.18M-7.40M-7.80M-7.53M-7.72M-7.17M-7.60M-8.56M-8.63M-7.09M-6.16M-5.55M-5.09M-3.85M-4.94M-5.09M-4.78M
Depreciation and DepletionDep. & Depletion
0.02M0.02M0.02M0.03M0.05M0.24M0.20M0.30M0.28M0.24M0.20M0.30M0.28M0.30M0.30M0.20M0.20M0.25M0.30M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.14M0.15M0.15M0.10M0.09M0.12M0.19M0.23M0.24M0.22M0.20M0.19M0.23M0.23M0.24M0.29M0.13M0.12M0.11M0.06M
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.02M0.02M0.03M0.05M0.24M0.20M0.30M0.28M0.24M0.20M0.30M0.28M0.30M0.30M0.20M0.20M0.25M0.30M
Share-based CompensationStock Comp.
0.48M0.97M0.76M0.88M0.90M0.92M0.86M1.02M1.24M1.25M1.24M1.17M1.76M0.83M0.83M0.96M0.69M0.71M0.40M0.35M
Other non-cash itemsOther Non-Cash
0.03M0.07M0.07M0.15M0.12M0.16M0.16M0.16M0.17M0.18M0.19M0.20M0.21M0.22M0.17M0.24M0.16M0.16M0.15M0.14M
Change in Working Capital
Change in Account PayablesChange Payables
0.41M-0.36M0.16M-0.15M0.70M0.80M-1.04M-0.36M0.21M0.20M0.49M0.03M-0.31M-0.75M0.19M-0.20M-0.18M0.11M0.14M-0.01M
Change in Other Operating AssetsOther Assets Change
3.32M-1.35M-0.79M0.18M0.74M2.07M-0.51M-1.07M1.22M-0.33M-0.54M-0.28M0.24M-1.30M-0.62M-0.32M0.46M-0.31M-0.08M-0.21M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.74M1.49M-0.36M0.19M0.84M-0.16M-0.84M0.01M0.58M0.34M-2.26M0.43M-0.98M0.05M0.12M-0.70M-0.26M1.15M-0.98M0.02M
Other Working Capital ChangesOther WC Changes
-4.06M2.84M0.43M0.01M0.10M-2.22M-0.33M1.08M-0.64M0.67M-1.72M0.71M-1.22M1.35M0.74M-0.38M-0.71M1.47M-0.90M0.23M
Cash from OperationsCash from Ops.
-6.37M-2.18M-4.56M-5.87M-5.74M-7.95M-7.44M-5.34M-5.71M-4.85M-7.92M-6.09M-6.11M-4.03M-3.12M-3.93M-3.52M-2.14M-4.95M-3.75M
Investing Activities
Capital ExpendituresCapex
0.16M0.25M0.43M1.76M1.26M0.43M0.02M0.08M0.07M0.07M0.08M0.03M0.01M0.23M
Change in Property, Plant and EquipmentChange in PP&E
-0.16M-0.25M-0.43M-1.76M-1.26M-0.43M-0.02M-0.08M-0.07M-0.07M-0.08M-0.03M-0.01M-0.23M
Cash from Investing ActivitiesCash from Investing
-0.16M-0.25M-0.43M-1.76M-1.26M-0.43M-0.02M-0.08M-0.07M-0.07M-0.08M-0.03M-0.01M-0.23M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.32M0.15M0.14M0.10M0.09M0.30M0.18M0.21M0.24M0.17M0.19M0.17M0.21M0.22M0.23M0.23M0.12M0.11M0.11M0.06M
Non-Current Debt
-0.32M-0.15M-0.14M-0.10M-0.09M-0.30M-0.18M-0.21M-0.24M-0.17M-0.19M-0.17M-0.21M-0.22M-0.23M-0.23M-0.12M-0.11M-0.11M-0.06M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.32M-0.15M-0.14M-0.10M-0.09M-0.30M-0.18M-0.21M-0.24M-0.17M-0.19M-0.17M-0.21M-0.22M-0.23M-0.23M-0.12M-0.11M-0.11M-0.06M
Change in Capital Stock
Common Stock IssuedStock Issued
36.33M0.03M0.03M0.03M0.04M0.72M11.71M1.89M13.53M3.53M-3.62M15.13M3.74M3.62M1.11M18.60M
Net Shares Issued and RepurchasedNet Shares Issued
36.33M0.03M0.03M0.03M0.04M0.72M11.71M1.89M13.53M3.53M-3.62M15.13M3.74M3.62M1.11M18.60M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
36.33M0.03M0.03M0.03M0.04M0.72M11.71M1.89M13.53M3.53M-3.62M15.13M3.74M3.62M1.11M18.60M
Other financing activitiesOther financing
-0.82M-1.10M-0.09M-0.09M0.09M-0.09M0.01M
Cash from Financing ActivitiesCash from Financing
35.19M-1.21M-0.10M-0.07M9.41M-0.25M0.55M11.49M1.65M13.35M-0.28M3.38M-0.11M11.19M3.89M5.27M0.99M18.49M-0.20M-0.05M
Additional items
Change in Cash
28.68M-3.54M-4.91M-6.36M1.91M-9.47M-7.32M6.13M-4.14M8.43M-8.27M-2.80M-6.22M7.13M0.77M1.34M-2.54M16.35M-5.15M-4.03M
Ending Cash Balance
40.68M37.27M32.36M25.99M27.90M18.43M11.11M17.25M13.11M21.54M10.48M4.26M11.39M13.50M10.96M27.31M18.13M
Free Cash FlowFCF
-6.37M-2.33M-4.81M-6.30M-7.51M-9.21M-7.87M-5.36M-5.79M-4.92M-7.99M-6.17M-6.11M-4.06M-3.12M-3.93M-3.52M-2.14M-4.96M-3.98M
Net Cash FlowNCF
28.83M-3.54M-4.91M-6.36M1.91M-9.47M-7.32M6.13M-4.14M8.43M-8.27M-2.80M-6.22M7.13M0.77M1.34M-2.54M16.35M-5.15M-4.03M

In8Bio Cash Flow Statement API

Pull In8Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INAB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY